Pentobarbital features inside the CNS by binding to gamma-aminobutyric acid (GABA) A subtype receptors. This action potentiates GABA effects, causing CNS depression and inhibiting glutamate, additional resulting in an additive effect on CNS melancholy. Even though the deficiency of an antidote has led to diminished very first-line use of the drug,